The effect of splitting on the quality and in vitro release of metformin hydrochloride from extended-release (XR) tablets

Authors

DOI:

https://doi.org/10.33448/rsd-v10i11.19348

Keywords:

Metformin hydrochloride; Drug release; Dissolution; Quality control; Diabetes mellitus.

Abstract

Metformin hydrochloride (MetCl) is used worldwide in the treatment of type-2 diabetes mellitus. Although extended-release (XR) tablets containing 500 mg, 850 mg, and 1000 mg of MetCl are marketed, it is not uncommon to split the tablet when the dosage form of the required strength is not available commercially. The aim of work was to evaluate the effects of splitting on the in vitro performance of XR tablets containing MetCl. We performed quality control assays and comparative dissolution profile studies among several medicines containing 500 mg and 1000 mg of MetCl, marketed in Brazil and Argentina. Tablets containing 1000 mg of MetCl were halved (test samples) and compared with whole tablets of products containing 500 mg of MetCl (reference samples). The halved tablets were more fragile and presented lower uniformity of mass and dosage unit as compared to the whole ones. However, it was evidenced by the F2 bootstrapping parameter that splitting MetCl XR tablets did not significantly impact the in vitro drug release profiles as compared to the whole tablets. In addition, nor the drug release mechanism neither the release kinetics were significantly affected. The XR tablets containing 1000 mg of metformin hydrochloride might be eligible for division, however, manufacturers could provide appropriate scores in the tablets surfaces to make the splitting proper and safer for the patients.

References

Abu-Geras, D., Hadziomerovic, D., Leau, A., Khan, R. N., Gudka, S., Locher, C., Razaghikashani, M., & Lim, L. Y. (2017). Accuracy of tablet splitting and liquid measurements: an examination of who, what and how. Journal of Pharmacy and Pharmacology, 69(5), 603–612. https://doi.org/10.1111/jphp.12671

Ashrafpour, R., Ayati, N., Sadeghi, R., Zare Namdar, S., Ayati, N., Ghahremani, S., & Zakavi, S. R. (2018). Comparison of Treatment Response Achieved by Tablet Splitting Versus Whole Tablet Administration of Levothyroxine in Patients with Thyroid Cancer. Asia Oceania Journal of Nuclear Medicine & Biology, 6(2), 108–112. https://doi.org/10.22038/aojnmb.2018.26793.1187

Balan, G., Timmins, P., Greene, D. S., & Marathe, P. H. (2001). In vitro-In vivo correlation (IVIVC) models for metformin after administration of modified-release (MR) oral dosage forms to healthy human volunteers. Journal of Pharmaceutical Sciences, 90(8), 1176–1185. https://doi.org/10.1002/jps.1071

BRASIL. (2019). Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Farmacopeia Brasileira (6a ed.), Fundação Oswaldo Cruz. http://portal.anvisa.gov.br/farmacopeia-brasileira

Carey, H., & Fondriest, M. (2017). Cost-savings from an antipsychotic tablet-splitting program. P and T, 42(6), 384–393.

Chou, C. L., Hsu, C. C., Chou, C. Y., Chen, T. J., Chou, L. F., & Chou, Y. C. (2015). Tablet splitting of narrow therapeutic index drugs: a nationwide survey in Taiwan. International Journal of Clinical Pharmacy, 37(6), 1235–1241. https://doi.org/10.1007/s11096-015-0194-0

de Melo, V. V., Pereira, G. R. S., Soares, A. Q., da Silva, I. C. R., Taveira, S. F., Cunha-Filho, M., & Marreto, R. N. (2020). Prevalence of tablet splitting in a brazilian tertiary care hospital. Pharmacy Practice, 18(2), 1–7. https://doi.org/10.18549/PharmPract.2020.2.1910

Elliott, I., Mayxay, M., Yeuichaixong, S., Lee, S. J., & Newton, P. N. (2014). The practice and clinical implications of tablet splitting in international health. Tropical Medicine & International Health : TM & IH, 19(7), 754–760. https://doi.org/10.1111/tmi.12309

Eserian, J. K., & Lombardo, M. (2017). Evaluation of Quality Attributes of Propranolol Split Tablets: Focus on Dose Variability. Infarma - Ciências Farmacêuticas, 29(4), 371. https://doi.org/10.14450/2318-9312.v29.e4.a2017.pp371-378

Fahelelbom, K. M. S., Al-Tabakha, M. M. M., Eissa, N. A. M., & Javadi, J. (2016). Evaluation of certain pharmaceutical quality attributes of lisinopril split tablets. Scientia Pharmaceutica, 84(4), 646–653. https://doi.org/10.3390/scipharm84040646

Freeman, M. K., White, W., & Iranikhah, M. (2012). Tablet splitting: a review of the clinical and economic outcomes and patient acceptance. Second of a 2-part series. Part 1 was published in May 2012 (Consult Pharm 2012;27:239-53). In Consultant Pharmacist (Vol. 27, Issue 6, pp. 421–430). Consult Pharm. https://doi.org/10.4140/TCP.n.2012.421

Gracia-Vásquez, S. L., González-Barranco, P., Camacho-Mora, I. A., González-Santiago, O., & Vázquez-Rodríguez, S. A. (2017). Medications that should not be crushed. Medicina Universitaria, 19(75), 50–63. https://doi.org/10.1016/j.rmu.2017.03.001

Graham, G. G., Punt, J., Arora, M., Day, R. O., Doogue, M. P., Duong, J. K., Furlong, T. J., Greenfield, J. R., Greenup, L. C., Kirkpatrick, C. M., Ray, J. E., Timmins, P., & Williams, K. M. (2011). Clinical pharmacokinetics of metformin. Clinical Pharmacokinetics, 50(2), 81–98. https://doi.org/10.2165/11534750-000000000-00000

Helmy, S. A. (2015). Tablet splitting: Is it worthwhile? Analysis of drug content and weight uniformity for half tablets of 16 commonly used medications in the outpatient setting. Journal of Managed Care Pharmacy, 21(1), 76–86. https://doi.org/10.18553/jmcp.2015.21.1.76

Hussain, R., Hassali, M. A., & Babar, Z.-U.-D. (2019). Quantitative Methods in Pharmacy Practice Research. In Encyclopedia of Pharmacy Practice and Clinical Pharmacy (Issue July, pp. 22–28). https://doi.org/10.1016/b978-0-12-812735-3.00603-8

Idkaidek, N., Arafat, T., Melhim, M., Alawneh, J., & Hakooz, N. (2011). Metformin IR versus XR pharmacokinetics in humans. Journal of Bioequivalence and Bioavailability, 3(10), 233–235. https://doi.org/10.4172/jbb.1000092

Korsmeyer, R., & Peppas, N. (1981). Effect of the morphology of hydrophilic polymeric matrices on the diffusion and release of water soluble drugs. Journal of Membrane Science, 9, 211–227. http://www.sciencedirect.com/science/article/pii/S0376738800802653

Lopes, C., Lobo, J., & Costa, P. (2005). Formas farmacêuticas de liberação modificada: polímeros hidrifílicos. Braz J Pharm Sci, 41(2), 143–154. http://www.scielo.br/pdf/rbcf/v41n2/28035.pdf

Mascarenhas Starling, F., Medeiros-Souza, P., Francisco De Camargos, E., Ferreira, F., Rodrigues Silva, A., & Homem-De-Mello, M. (2015). Tablet Splitting of Psychotropic Drugs for Patients with Dementia: A Pharmacoepidemiologic Study in a Brazilian Sample. Clinical Therapeutics, 37(10), 2332–2338. https://doi.org/10.1016/j.clinthera.2015.08.015

Nasri, H., & Rafieian-Kopaei, M. (2014). Metformin: Current knowledge. Journal of Research in Medical Sciences, 19(7), 658–664.

Nidanapu, R. P., Rajan, S., Mahadevan, S., & Gitanjali, B. (2016). Tablet Splitting of Antiepileptic Drugs in Pediatric Epilepsy: Potential Effect on Plasma Drug Concentrations. Pediatric Drugs, 18(6), 451–463. https://doi.org/10.1007/s40272-016-0193-1

Paixão, P., Gouveia, L. F., Silva, N., & Morais, J. A. G. (2017). Evaluation of dissolution profile similarity – Comparison between the f2, the multivariate statistical distance and the f2 bootstrapping methods. European Journal of Pharmaceutics and Biopharmaceutics, 112(September 2018), 67–74. https://doi.org/10.1016/j.ejpb.2016.10.026

Siepmann, J., & Peppas, N. A. (2012). Modeling of drug release from delivery systems based on hydroxipropilmethylcellulose (HPMC). Advanced Drug Delivery Reviews, 64, 163–174.

Simionato, L. D., Petrone, L., Baldut, M., Bonafede, S. L., & Segall, A. I. (2018). Comparison between the dissolution profiles of nine meloxicam tablet brands commercially available in Buenos Aires , Argentina. Saudi Pharmaceutical Journal, 26(4), 578–584. https://doi.org/10.1016/j.jsps.2018.01.015

Teixeira, M. T., Sá-Barreto, L. C. L., Gratieri, T., Gelfuso, G. M., Silva, I. C. R., & Cunha-Filho, M. S. S. (2017). Key Technical Aspects Influencing the Accuracy of Tablet Subdivision. AAPS PharmSciTech, 18(4), 1393–1401. https://doi.org/10.1208/s12249-016-0615-y

The United States Pharmacopeia and National Formulary - USP 42, N. 37 ed. rev. (2019). Rockville: United States Pharmacopeial Convention.

Tranchard, F., Hein, C., Lacombe, J., Villars, H., Montastruc, J.-L., & Despas, F. (2016). Medication errors and look-alike tablets: the splitting issue. Pharmacoepidemiology and Drug Safety, 25(July), 1002–1003. https://doi.org/10.1002/pds.4063

Van Riet-Nales, D. A., Doeve, M. E., Nicia, A. E., Teerenstra, S., Notenboom, K., Hekster, Y. A., & Van Den Bemt, B. J. F. (2014). The accuracy, precision and sustainability of different techniques for tablet subdivision: Breaking by hand and the use of tablet splitters or a kitchen knife. International Journal of Pharmaceutics, 466(1–2), 44–51. https://doi.org/10.1016/j.ijpharm.2014.02.031

Vranić, E., & Uzunović, A. (2007). Influence of tablet splitting on content uniformity of lisinopril/hydrochlorthiazide tablets. Bosnian Journal of Basic Medical Sciences / Udruženje Basičnih Mediciniskih Znanosti = Association of Basic Medical Sciences, 7(4), 328–334. https://doi.org/10.17305/bjbms.2007.3022

Vranić, E., & Uzunović, A. (2009). Influence of splitting on dissolution properties of metoprolol tablets. Bosnian Journal of Basic Medical Sciences, 9(3), 245–249. https://doi.org/10.17305/bjbms.2009.2815

Wilczyński, S., Koprowski, R., Duda, P., Banyś, A., & Błońska-Fajfrowska, B. (2016). Microtomographic studies of subdivision of modified-release tablets. International Journal of Pharmaceutics, 511(2), 899–912. https://doi.org/10.1016/j.ijpharm.2016.07.069

World Health Organization (WHO). (2019). The International Pharmacopoeia 9th Ed. Geneva: World Health Organization, Dept. of Essential Medicines and Pharmaceutical Policies. https://apps.who.int/phint/en/p/about/

Zhang, Y., Huo, M., Zhou, J., Zou, A., Li, W., Yao, C., & Xie, S. (2010). DDSolver: An add-in program for modeling and comparison of drug dissolution profiles. AAPS Journal, 12(3), 263–271. https://doi.org/10.1208/s12248-010-9185-1

Zuo, J., Gao, Y., Bou-Chacra, N., & Löbenberg, R. (2014). Evaluation of the DDSolver software applications. BioMed Research International, 2014(April 2015). https://doi.org/10.1155/2014/204925

Published

04/09/2021

How to Cite

SANTOS, L. G. da F.; SEGALL, A. I. .; KI HAN, Y.; KIZELMAN, M. P.; FERREIRA, M. P. .; SILVA, A. C. F. .; MARTINS, F. S. .; CASTRO, W. V. de .; FREITAS, O. de; COUTO, R. O. do. The effect of splitting on the quality and in vitro release of metformin hydrochloride from extended-release (XR) tablets. Research, Society and Development, [S. l.], v. 10, n. 11, p. e368101119348, 2021. DOI: 10.33448/rsd-v10i11.19348. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/19348. Acesso em: 24 dec. 2024.

Issue

Section

Health Sciences